Clinical trial
Naltrexone Implants as Relapse Prevention
NCT00269607 · University of Oslo, Other · Terminated
Key facts
| NCT number | NCT00269607 |
|---|---|
| Title | Naltrexone Implants as Relapse Prevention |
| Official title | Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction. |
| Lead sponsor | University of Oslo, Other |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Opioid Dependency |
| Intervention type | Drug |
| Interventions | Implantation of naltrexone implants |
| Enrollment | 12 |
| Start date | May 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Dec 23, 2005 |
| Last update posted | Dec 11, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: